At 7TM Pharma we focus on developing our pipeline of clinical assets forward with a primary therapeutic focus in obesity, diabetes and related metabolic diseases. These are areas with obvious unmet medicinal needs. According to the WHO, there are more than 400 million clinically obese people worldwide, and the number is growing rapidly.
Management
Christian E. Elling, PhD
Chief Executive Officer
Ulrik Vejlsgaard
Chief Financial Officer
Chairman of the Board